| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 06/06/2006 | US7056708 Starting from 1-((optionally substituted-phenyl)sulfanyl)alkanes to form a polylactone having said phenylsulfide side groups |
| 06/06/2006 | US7056704 RNA interference mediating small RNA molecules |
| 06/06/2006 | US7056701 Hormone and albumin fusion protein |
| 06/06/2006 | US7056697 FabK variant |
| 06/06/2006 | US7056694 DNA encoding peripheral-type benzodiazipine receptor associated protein 7 and applications or methods of use |
| 06/06/2006 | US7056688 LDL receptor signaling assays |
| 06/06/2006 | US7056679 Mixing in a reaction vessel phage expressing biological targets and phage expressing target binders each having distinguishable selection markers, selecting target and target binder pairs based on the selection markers |
| 06/06/2006 | US7056672 insertion of nucleotides into genetic vectors comprising nucleotide sequences, then transfection into host cells, culturing under conditions permitting gene expression and analyzing for labelled polypeptides; genetic engineering |
| 06/06/2006 | US7056516 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders |
| 06/06/2006 | US7056512 controlling and increasing muscle growth, especially in farm animals for slaughter, by administering an immunogenically effective amount ofa modified GDF-8 polypeptide |
| 06/06/2006 | US7056510 Streptococcus pneumoniae SP036 polynucleotides, polypeptides, antigens and vaccines |
| 06/06/2006 | US7056502 Recombinant aav vectors with AAV5 capsids and AAV5 vectors pseudotyped in heterologous capsids |
| 06/06/2006 | CA2386587C Genes and proteins for the biosynthesis of anthramycin |
| 06/06/2006 | CA2318813C Highly efficient controlled expression of exogenous genes in e. coli |
| 06/06/2006 | CA2120153C Recombinant immunotoxins |
| 06/06/2006 | CA2116980C Chimeric and/or growth-restricted flaviviruses |
| 06/06/2006 | CA2053288C Expression of human apolipoproteins ai and ai-milano in yeast |
| 06/03/2006 | CA2526272A1 Polypeptides involved in candida biofilm formation and uses thereof |
| 06/01/2006 | WO2006057450A1 L-amino acid-producing bacterium and a method for producing l-amino acid |
| 06/01/2006 | WO2006057389A1 Novel transcriptional factor phosphorylated by amp protein kinase and gene thereof |
| 06/01/2006 | WO2006057341A1 Industrially useful microorganism |
| 06/01/2006 | WO2006057289A1 Novel shuttle vector |
| 06/01/2006 | WO2006056853A1 Methods for cultivating lawsonia intracellularis |
| 06/01/2006 | WO2006056597A1 Yeast strain and screening method for identifying inhibitors of the expression of the hexose transporter genes by a positive phenotype |
| 06/01/2006 | WO2006056306A2 Hydrogel polymeric conjugates of a prodrug |
| 06/01/2006 | WO2006056050A1 Production of heterologous proteins in caulobacter |
| 06/01/2006 | WO2006017576A3 Microbial reductive dehalogenation of vinyl chloride |
| 06/01/2006 | WO2005121331A9 Truncated galnact2 polypeptides and nucleic acids |
| 06/01/2006 | WO2005019426A3 Gene cluster for fostriecin biosynthesis |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060117414 Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof |
| 06/01/2006 | US20060117401 Method for producing aminoacids |
| 06/01/2006 | US20060116506 Tenebrio antifreeze proteins |
| 06/01/2006 | US20060116348 Using the hyaluronate synthase from Pasteurella multocida; coatings for biomaterials wherein the coatings provide protective properties to the biomaterial and/or act as a bioadhesive; coatings could be applied to electrical devices, sensors, catheters |
| 06/01/2006 | US20060116315 Method of screening agent for improving memory and learning ability |
| 06/01/2006 | US20060115886 decompose a glycoside having soyasapogenol B as an aglycone to produce soyasapogenol B; a polynucleotide encoding such a protein; soyasapogenol B can be obtained independently of the saponin content of, for example, a soybean extract; host is filamentous fungus belonging to genus Trichoderma, aspergillus |
| 06/01/2006 | US20060115883 Regioselective hydrolysis of (E)-2-methyl-2-butenonitrile to (E)-2-methyl-2-butenoic acid (2M2BA) using enzyme catalysts having either a nitrilase activity or both of nitrile hydratase and amidase activities |
| 06/01/2006 | US20060115881 High eicosapentaenoic acid producing strains of Yarrowia lipolytica |
| 06/01/2006 | US20060115879 Process for producing anticancer agent LL-D45042 |
| 06/01/2006 | US20060115878 Method for producing L-amino acid |
| 06/01/2006 | US20060115872 Culture medium and a method for detection of parasites |
| 06/01/2006 | US20060115844 Enhanced amplifiability of minute fixative-treated tissue samples, minute stained cytology samples, and other minute sources of DNA |
| 06/01/2006 | US20060115831 Map |
| 06/01/2006 | US20060115813 Intracellular signaling molecules |
| 06/01/2006 | US20060115805 Gelatine-based materials as swabs |
| 06/01/2006 | US20060115497 Mycobacterium strains with modified erp gene and vaccine composition containing same |
| 06/01/2006 | US20060115494 Recombinant BCG strains with attenuated immunosuppressive properties |
| 06/01/2006 | US20060115493 Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof |
| 06/01/2006 | US20060115491 Vaccine delivery; attaching immunogenic determinant of heterologous polypeptide biodrug to the peptidoglycan microparticle on cell wall of a Gram-positive bacterium; improve the binding by treating the cell wall with acid solution to remove protein, lipotechoic, carbohydrates |
| 06/01/2006 | US20060115490 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection |
| 06/01/2006 | US20060115484 Nucleic acid for modulating apoptosis |
| 06/01/2006 | DE102004056302A1 Treatment of radioactively contaminated material (milk powder) comprises treatment with photosynthetic and/or luminescent bacteria in a biological solution preferably containing conjugated polymers and nano-composites |
| 06/01/2006 | CA2589754A1 Yeast strain and screening method for identifying inhibitors of the expression of the hexose transporter genes by a positive phenotype |
| 06/01/2006 | CA2586126A1 Novel shuttle vector |
| 06/01/2006 | CA2586093A1 Methods for cultivating lawsonia intracellularis |
| 05/31/2006 | EP1661994A1 Therapeutic agent for NGF |
| 05/31/2006 | EP1661990A1 Polypeptide specific to liver cancer, polynucleotide encoding the polypeptide and rna molecule inhibiting the expression of the polypeptide |
| 05/31/2006 | EP1661981A1 Yeast strain and screening method for identifying inhibitors of the expression of the hexose transporter genes by a positive phenotype |
| 05/31/2006 | EP1661910A1 Peptides capable of binding to titanium, silver and silicone |
| 05/31/2006 | EP1660669A2 Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives and vicinal cyano, hydroxy substituted carboxylic acid esters |
| 05/31/2006 | EP1660667A2 Microorganisms and processes for enhanced production of pantothenate |
| 05/31/2006 | EP1660650A2 Improved sso7-polymerase conjugate proteins |
| 05/31/2006 | EP1660649A1 Method for detoxification of mycotoxins |
| 05/31/2006 | EP1660640A2 Ferment activator based on lactic acid bacteria, and method of preparing a product using said activator |
| 05/31/2006 | EP1660639A1 Method for increasing yield of biomass of and/or components of biomass from marine microorganisms |
| 05/31/2006 | EP1660638A2 Lipoparticles comprising proteins, methods of making, and using the same |
| 05/31/2006 | EP1660632A2 Human skin equivalents expressing exogenous polypeptides |
| 05/31/2006 | EP1660508A2 Use of novel compounds to release nucleotides from living cells |
| 05/31/2006 | EP1660121A2 Live attenuated bacterial vaccine |
| 05/31/2006 | EP1660120A1 Live attenuated aldolase-negative bacterial vaccine |
| 05/31/2006 | EP1659859A1 Method for producing avian chimera using spermatogonial cells and avian chimera |
| 05/31/2006 | EP1576194B1 Bacterial strains of delftia acidovorans mc1-r, their production and their use in the production of the r enantiomers of 2-phenoxypropionic acid derivatives |
| 05/31/2006 | EP1313855B1 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 05/31/2006 | EP1272611B1 Streptomyces galbus strain with insecticidal activity and method of using as an insecticide |
| 05/31/2006 | EP1268798B1 Anti-angiogenic properties of vascostatin and fragments or variants thereof |
| 05/31/2006 | EP1250416B1 Artificial three-dimensional mammal heart muscle tissue and process for its manufacture |
| 05/31/2006 | EP1231270B1 Novel protein and dna thereof |
| 05/31/2006 | EP1230371B1 Method for producing recombinant interleucin-8 and interleucin-8 muteins and their use for screening il-8 receptor antagonists |
| 05/31/2006 | EP1198580B1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 05/31/2006 | EP1141336B1 Variants of egiii-like cellulase and compositions thereof |
| 05/31/2006 | EP1108014B1 Ehrlichia canis protein |
| 05/31/2006 | EP1090136B1 Mumbaistatin, a process for its production and its use as a pharmaceutical |
| 05/31/2006 | EP1066374B1 Amylolytic enzyme variants |
| 05/31/2006 | EP1054956B1 Lipase variant |
| 05/31/2006 | EP1025235B1 Expression system |
| 05/31/2006 | EP1019521B1 A process for the biotransformation of colchicone compounds into the corresponding 3-glycosyl derivatives |
| 05/31/2006 | EP0970228B1 Methods and means for gene silencing in transgenic plants |
| 05/31/2006 | EP0941352B1 Improvements in or relating to starch content of plants |
| 05/31/2006 | EP0914437B1 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin |
| 05/31/2006 | EP0894142B1 Microbial oil containing a polyunsaturated fatty acid and method of producing oil from pasteurised and granulated biomass |
| 05/31/2006 | EP0861321B1 Phosphopantetheinyl transferases and uses thereof |
| 05/31/2006 | EP0840789B1 Transketolase-related protein |
| 05/31/2006 | EP0791076B1 Diagnostic method and kit for determining kell blood group genotype |
| 05/31/2006 | EP0757717B1 Papillomavirus vaccines |
| 05/31/2006 | CN1780918A Method of producing 1,2-propanediol using klebsiella pneumoniae |
| 05/31/2006 | CN1780906A Basidiomycetes, basidiomycetes extract composition, and health foods and immunopotentiators |
| 05/31/2006 | CN1780905A Process for the production of biological substances by perfusion culturing of suspended animal cells |
| 05/31/2006 | CN1780554A Clinically relevant animal model of human breast cancer and VEGF involvement in desmoplastic response, tamoxifen resistance and metastasis |
| 05/31/2006 | CN1778926A Modified pig propagation and respiratory syndrome virus ORF5 gene and use thereof |
| 05/31/2006 | CN1778914A Expression of soluble TRAIL protein |